|
R
Cancer
genetics, Leukemia, Breast cancer, Chromosome instability, Fanconi
anemia, DNA Repair, DNA replication stress, Chromosomal fragile site
stability, Homologous recombination
The study of the cellular DNA damage response is of immense importance
to our health and wellbeing. Our DNA is exposed to a continual flux of
intrinsic (e.g. reactive oxygen species generated during oxidative
metabolism) and extrinsic (e.g. ultraviolet radiation (UV)) DNA
damaging agents. How our cells respond to DNA damage defines our cancer
risk, and also determines how we respond to chemo- and
radiation-therapy. The importance of the cellular DNA damage response
is underscored by the numerous cancer susceptibility disorders caused
by mutations in DNA damage response genes, e.g. Ataxia-telangiectasia,
Fanconi anemia, and Xeroderma pigmentosum. Furthermore, an impaired
cellular DNA damage response is not solely associated with an elevated
cancer risk: diverse clinical manifestations including various
neuropathies, immune defects, mental retardation, limb and digit
anomalies, and hematopoiesis defects, are often observed in these
syndromes.
I am
particularly interested in Fanconi anemia (FA). FA is a rare recessive
disorder characterized by congenital defects, e.g. microcephaly, skin
hyperpigmentation, and hand and arm anomalies, early onset
hematological abnormalities, e.g. bone marrow failure and acute myeloid
leukemia (AML), and solid tumors, including head, neck, esophagus, and
gynecological squamous cell carcinomas (SCC). The incidence of FA is
estimated to be between 1 and 3 per million live births. FA is a
genetically heterogeneous disease with thirteen distinct
complementation groups defined to date (A, B, C, D1/BRCA2, D2, E, F, G,
I, J/BRIP1, L, M, and N/PALB2), and all thirteen of the underlying
genes have been cloned or identified.
At the cellular level, the hallmark of FA is
a marked sensitivity to
DNA interstrand crosslinking agents, e.g. mitomycin C. DNA interstrand
crosslinks represent a particularly cytotoxic lesion, preventing DNA
strand separation during DNA replication and transcription. Indeed, DNA
crosslinking agents are widely used, and highly effective,
chemotherapeutic agents, e.g. cyclophosphamide and cisplatin. Thus, the
FA pathway represents an attractive target for the chemo-sensitization
of tumor cells.
Despite many recent exciting breakthroughs
in FA gene identification,
how the FA proteins co-operatively function in the DNA damage response,
and prevent neoplastic transformation and cancer, remains to be
elucidated. I am interested in addressing several important FA
questions, including the following:
- What is
the in vivo physiological function of the FA pathway?
- What is
the specific DNA lesion(s) that activates the FA pathway?
- What is
the molecular basis for the increased frequency of HPV-associated
tumorigenesis among FA patients?
If you are interested in joining the laboratory please email me at
nhowlett@mail.uri.edu
B
1. Howlett, N.G.
(2007).
Fanconi anemia, breast and embryonal cancer revisited. European Journal of Human Genetics,
15, 715-717.
2. Durkin S.G., Arlt, M.F., Howlett,
N.G., and Glover, T.W. (2006). Depletion of CHK1, but not
CHK2,
induces chromosomal instability and common fragile site
breakage. Oncogene,
25,
4381-4388.
3. Howlett N.G.,
Scuric, Z,
D’Andrea, A.D., and Schiestl, R.H. (2006). Impaired DNA
double strand
break repair in cells from Nijmegen Breakage Syndrome
patients. DNA
Repair, 5, 251-257.
4. Howlett N.G.,
Taniguchi,
T., Durkin S.G., D’Andrea, A.D., and Glover, T.W.
(2005). The
Fanconi anemia pathway is required for the DNA replication stress
response and the regulation of common fragile site stability.
Human
Molecular Genetics, 14,
693-701.
5. Secretan M.B., Scuric Z., Oshima J., Bishop A.J., Howlett N.G., Yau
D., Schiestl R.H.
(2004). Effect of Ku86 and DNA-PKcs deficiency on
non-homologous
end-joining and homologous recombination using a transient transfection
assay. Mutation
Research,
554, 351-364.
6. Egorov A.I., Howlett
N.G.,
Schiestl R.H. (2004). Mutagen X and chlorinated tap water are
recombinagenic in yeast. Mutation
Research, 563, 159-169.
7. Howlett, N.G.
and Schiestl,
R.H. (2004). Nucleotide excision repair deficiency causes
elevated levels of chromosome gain in Saccharomyces cerevisiae. DNA Repair, 3,
127-134.
8. Liu, T.X., Howlett,
N.G.,
Deng, M., Langenau, D.M., Hsu, K., Rhodes, J., Kanki, J.P.,
D’Andrea,
A.D., and Look, T.A. (2003). Disruption of zebrafish fancd2
causes developmental abnormalities via p53-dependent apoptosis. Developmental Cell,
5, 903-914.
9. Vonarx, E.J., Howlett,
N.G.,
Schiestl, R.H., and Kunz, B.A. (2002). Detection of
Arabidopsis
thaliana AtRAD1 cDNA variants and assessment of function by expression
in a yeast rad1 mutant. Gene,
296, 1-9.
10. Howlett, N.G.,
Taniguchi,
T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N.,
Grompe, M., Joenje, H., Pals, G., Ikeda, H., Fox, E.A., and
D’Andrea,
A.D. (2002). Biallelic inactivation of BRCA2 in Fanconi
Anemia. Science,
297,
606-609.
11. Howlett, N.G.
and
Schiestl, R.H. (2000). Simultaneous measurement of the
frequencies of homologous recombination and chromosome gain using the
yeast DEL assay. Mutation
Research, 454, 53-62.
12. Howlett, N.G.
and Avery,
S.V. (1999). Flow cytometric investigation of heterogeneous
copper-sensitivity in asynchronously grown Saccharomyces
cerevisiae. FEMS
Microbiology
Letters, 176, 379-386.
13. Howlett, N.G.
and Avery,
S.V. (1997). Induction of lipid peroxidation during heavy
metal
stress in Saccharomyces cerevisiae and influence of plasma membrane
fatty acid unsaturation. Applied
and Environmental Microbiology, 63, 2971-2976.
14. Howlett, N.G.
and Avery,
S.V. (1997). Relationship between cadmium sensitivity and
degree
of plasma membrane fatty acid unsaturation in Saccharomyces
cerevisiae. Applied
Microbial
Biotechnology, 48, 539-545.
15. Avery, S.V., Howlett,
N.G.
and Radice, S. (1996). Copper toxicity towards Saccharomyces
cerevisiae: Dependence on plasma membrane fatty acid
composition. Applied
and Environmental
Microbiology, 62, 3960-3966.
|